Company news

Illumina, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Illumina to Webcast Upcoming Investor Conference

July 27, 2021

Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase

July 21, 2021

Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021

July 12, 2021

Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis

May 31, 2021

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand

May 30, 2021

Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development

May 16, 2021

Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition

April 28, 2021

Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative

April 27, 2021

Illumina Reports Financial Results for First Quarter of Fiscal Year 2021

April 26, 2021

Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic

April 21, 2021

Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test

April 19, 2021

Illumina Announces Preliminary Revenue for First Quarter Fiscal Year 2021

April 4, 2021

Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test

March 29, 2021

Illumina Announces Board Changes

March 17, 2021

Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women

March 10, 2021

Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia

March 4, 2021

Illumina and the University Hospital of Tübingen Evaluate Potential of Whole Genome Sequencing to Improve Diagnosis of Full Range of Genetic Diseases

February 18, 2021

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2020

February 10, 2021

Illumina to Webcast Upcoming Investor Conference Presentations

February 9, 2021

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle

February 7, 2021

Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium

February 3, 2021

Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China

January 30, 2021

Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021

January 24, 2021

Illumina Wins Patent Infringement Suit against BGI in the UK

January 19, 2021

Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling

January 10, 2021

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

January 4, 2021

Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing

December 7, 2020

Illumina to Webcast Upcoming Investor Conference Presentation

November 17, 2020

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020

October 28, 2020

Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020

September 27, 2020

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

September 20, 2020

Genomic Leaders Collaborate to Create Australia’s First National COVID-19 Tracking System

September 13, 2020

Illumina Welcomes Kathryne Reeves as Chief Marketing Officer

August 24, 2020

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2020

August 5, 2020

Illumina Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome

August 5, 2020

Illumina to Announce Second Quarter 2020 Financial Results on Thursday, August 6, 2020

July 15, 2020

Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases

July 7, 2020

Illumina Accelerator Welcomes First Global Cohort of Genomics Startups

June 22, 2020

Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale

June 16, 2020

Illumina Inc. Announces that U.S. Federal Court Issues Preliminary Injunction Against BGI Companies

June 15, 2020

Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test

June 8, 2020

Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research

May 17, 2020

Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development

May 3, 2020

Illumina Reports Financial Results for First Quarter of Fiscal Year 2020

April 29, 2020

Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance

April 27, 2020

Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19

April 15, 2020

Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020

April 13, 2020

Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

February 26, 2020

Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors

February 5, 2020

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019

January 28, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 50 decks. Every deck is listed under its year.